Ceforanide

Ceforanide
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Intramuscular
ATC code	J01DC11 ( WHO );
Pharmacokinetic data
Protein binding	80.6%
Metabolism	Nil
Elimination half-life	2.6 to 2.98 hours
Excretion	Renal
Identifiers
	IUPAC name (6R,7R)-7-{[2-[2-(aminomethyl)phenyl]acetyl]amino}-3-; {[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl}-8-oxo-; 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;
CAS Number	60925-61-3 ;
PubChem CID	43507 ;
DrugBank	DB00923 ;
ChemSpider	39656 ;
UNII	8M1YF8951V ;
KEGG	D00259 ;
ChEBI	CHEBI:3495 ;
ChEMBL	ChEMBL1201046 ;
NIAID ChemDB	007642 ;
CompTox Dashboard (EPA)	DTXSID1022760 ;
Chemical and physical data
Formula	C20H21N7O6S2
Molar mass	519.55 g·mol−1
3D model (JSmol)	Interactive image ;
	SMILES O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)Cc3ccccc3CN)CSc4nnnn4CC(=O)O)C(=O)O;
	InChI InChI=1S/C20H21N7O6S2/c21-6-11-4-2-1-3-10(11)5-13(28)22-15-17(31)27-16(19(32)33)12(8-34-18(15)27)9-35-20-23-24-25-26(20)7-14(29)30/h1-4,15,18H,5-9,21H2,(H,22,28)(H,29,30)(H,32,33)/t15-,18-/m1/s1 ; Key:SLAYUXIURFNXPG-CRAIPNDOSA-N ;
	(what is this?) (verify)

Last updated April 14, 2025

Ceforanide is a second-generation cephalosporin antibiotic.^[1]^[2]^[3]

References

↑ Crowle A, Sbarbaro J, May M (1988). "Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophages". Tubercle. 69 (1): 15–25. doi:10.1016/0041-3879(88)90036-0. PMID 3140456.
↑ Campoli-Richards D, Lackner T, Monk J (1987). "Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy". Drugs. 34 (4): 411–37. doi:10.2165/00003495-198734040-00001. PMID 3315624. S2CID 242440792.
↑ Cone L, Barton S, Woodard D (1987). "Treatment of scleroma with ceforanide". Arch Otolaryngol Head Neck Surg. 113 (4): 374–6. doi:10.1001/archotol.1987.01860040036012. PMID 3814386.

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[1] Crowle A, Sbarbaro J, May M (1988). "Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophages". Tubercle. 69 (1): 15–25. doi:10.1016/0041-3879(88)90036-0. PMID 3140456.

[2] Campoli-Richards D, Lackner T, Monk J (1987). "Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy". Drugs. 34 (4): 411–37. doi:10.2165/00003495-198734040-00001. PMID 3315624. S2CID 242440792.

[3] Cone L, Barton S, Woodard D (1987). "Treatment of scleroma with ceforanide". Arch Otolaryngol Head Neck Surg. 113 (4): 374–6. doi:10.1001/archotol.1987.01860040036012. PMID 3814386.

[1]

[2]

[3]

Clinical data

AHFS/Drugs.com	International Drug Names
Routes of administration	Intramuscular
ATC code	J01DC11 ( WHO )
Pharmacokinetic data
Protein binding	80.6%
Metabolism	Nil
Elimination half-life	2.6 to 2.98 hours
Excretion	Renal
Identifiers
IUPAC name (6R,7R)-7-{[2-[2-(aminomethyl)phenyl]acetyl]amino}-3- {[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl}-8-oxo- 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS Number	60925-61-3 ^Y
PubChem CID	43507
DrugBank	DB00923 ^Y
ChemSpider	39656 ^Y
UNII	8M1YF8951V
KEGG	D00259 ^Y
ChEBI	CHEBI:3495 ^Y
ChEMBL	ChEMBL1201046 ^N
NIAID ChemDB	007642
CompTox Dashboard (EPA)	DTXSID1022760
Chemical and physical data
Formula	C₂₀H₂₁N₇O₆S₂
Molar mass	519.55 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)Cc3ccccc3CN)CSc4nnnn4CC(=O)O)C(=O)O
InChI InChI=1S/C20H21N7O6S2/c21-6-11-4-2-1-3-10(11)5-13(28)22-15-17(31)27-16(19(32)33)12(8-34-18(15)27)9-35-20-23-24-25-26(20)7-14(29)30/h1-4,15,18H,5-9,21H2,(H,22,28)(H,29,30)(H,32,33)/t15-,18-/m1/s1^Y Key:SLAYUXIURFNXPG-CRAIPNDOSA-N^Y
^NY (what is this?) (verify)

Ceforanide

See also

References